Therapix Biosciences Ltd ADR | TalkMarkets

Article By: Stone Fox Capital

Wednesday, March 22, 2017 11:48 AM EDT

Therapix Bio offers investors an under the radar IPO in the hot cannabinoid market with a promising pipeline.

In this article: THXBY, TRPX, SPRCY Also: GWPH, ZYNE, OWCP, CNBX

Article By: ChinaBio® Today

Sunday, December 28, 2014 6:01 AM EDT

Otsuka will pay $77.5 million upfront plus additional regulatory milestones. Ariad will receive a "substantial" share of net product revenues.

In this article: ARIA, CRME, CRPNF, THXBY, OTSKF